Pharma Mar SA (PHMMF)
94.60
0.00 (0.00%)
USD |
OTCM |
Sep 10, 16:00
Pharma Mar Gross Profit (TTM) : 228.39M for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 228.39M |
| March 31, 2026 | 239.43M |
| December 31, 2025 | 233.27M |
| September 30, 2025 | 182.64M |
| June 30, 2025 | 193.95M |
| March 31, 2025 | 176.00M |
| December 31, 2024 | 177.97M |
| September 30, 2024 | 170.99M |
| June 30, 2024 | 160.36M |
| March 31, 2024 | 165.78M |
| December 31, 2023 | 160.66M |
| September 30, 2023 | 169.42M |
| June 30, 2023 | 179.57M |
| March 31, 2023 | 186.75M |
| December 31, 2022 | 246.57M |
| June 30, 2022 | 245.94M |
| March 31, 2022 | 253.61M |
| December 31, 2021 | 252.79M |
| September 30, 2021 | 210.47M |
| June 30, 2021 | 217.11M |
| March 31, 2021 | 234.33M |
| December 31, 2020 | 287.03M |
| September 30, 2020 | 258.15M |
| June 30, 2020 | 222.80M |
| March 31, 2020 | 172.00M |
| Date | Value |
|---|---|
| December 31, 2019 | 83.81M |
| September 30, 2019 | 82.14M |
| June 30, 2019 | 86.42M |
| March 31, 2019 | 107.47M |
| December 31, 2018 | 119.35M |
| September 30, 2018 | 132.76M |
| June 30, 2018 | 145.58M |
| March 31, 2018 | 143.21M |
| December 31, 2017 | 148.80M |
| September 30, 2017 | 150.54M |
| June 30, 2017 | 152.80M |
| March 31, 2017 | 153.23M |
| December 31, 2016 | 151.62M |
| September 30, 2016 | 178.44M |
| June 30, 2016 | 171.98M |
| March 31, 2016 | 168.90M |
| December 31, 2015 | 163.81M |
| September 30, 2015 | 131.73M |
| June 30, 2015 | 134.54M |
| March 31, 2015 | 139.14M |
| December 31, 2014 | 144.99M |
| September 30, 2014 | 148.16M |
| June 30, 2014 | 149.36M |
| March 31, 2014 | 145.80M |
| December 31, 2013 | 141.61M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Oryzon Genomics SA | -0.1475M |
| Grifols SA | 3.201B |
| ACADIA Pharmaceuticals, Inc. | 1.038B |
| Alkermes Plc | 1.370B |
| Alnylam Pharmaceuticals, Inc. | 3.827B |